Glaucoma Therapeutics Market on Track to Reach US$ 10 Billion by 2031 – X herald

The glaucoma therapeutics market encompasses a range of pharmaceutical and surgical interventions aimed at managing and treating glaucoma, a group of eye diseases characterized by increased intraocular pressure (IOP) that can lead to optic nerve damage and vision loss if left untreated. As one of the leading causes of irreversible blindness worldwide, glaucoma presents a significant healthcare challenge, and the market for glaucoma therapeutics is critical in addressing this global issue.


read more..